Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate
- PMID: 3965240
- DOI: 10.1038/clpt.1985.17
Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate
Abstract
Eleven healthy subjects received five doses of intravenous sodium dichloroacetate (DCA) at 2-hr intervals. Determinations of DCA in plasma and of lactate and glucose in blood were made at various times until 24 hr after starting the first infusion. Twenty-four-hour urinary oxalate excretion was also measured. DCA levels rose and fell during and after each dose, with higher levels induced by higher doses. Lactate levels fell as the result of DCA treatment, with greater falls after higher doses, and returned to normal after 24 hr at the two lower dose levels but not at the level of 50 mg/kg. Lactate levels did not change parallel to changes in DCA levels. Only the doses of 50 mg/kg prevented postprandial rises in lactate levels. Blood glucose levels were not altered. The mean DCA t1/2 after the initial doses was 63.3 min (range 15.0 to 112.2 min), while that after the final doses was 374.0 min (range 37.8 to 1386.0 min). The AUC and the DCA-induced increase in urinary oxalate excretion were linearly related to dose. Mean DCA apparent volume of distribution was 0.30 l/kg (range 0.09 to 0.60 l/kg).
Similar articles
-
Comparative metabolic effects of acetate and dichloroacetate infusion in the anesthetized dog.Metabolism. 1985 Jul;34(7):680-7. doi: 10.1016/0026-0495(85)90098-8. Metabolism. 1985. PMID: 3925292
-
Effects of various doses of sodium dichloroacetate on hyperlactatemia in fed ischemic rats.Ann Emerg Med. 1989 Nov;18(11):1162-71. doi: 10.1016/s0196-0644(89)80053-8. Ann Emerg Med. 1989. PMID: 2683899 Review.
-
Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate.Biochem Pharmacol. 1982 Apr 1;31(7):1295-300. doi: 10.1016/0006-2952(82)90019-3. Biochem Pharmacol. 1982. PMID: 7092922
-
Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans.Anesthesiology. 1994 Nov;81(5):1127-38. doi: 10.1097/00000542-199411000-00006. Anesthesiology. 1994. PMID: 7978471 Clinical Trial.
-
The pharmacology of dichloroacetate.Metabolism. 1989 Nov;38(11):1124-44. doi: 10.1016/0026-0495(89)90051-6. Metabolism. 1989. PMID: 2554095 Review.
Cited by
-
Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer.J Cancer Res Clin Oncol. 2014 Mar;140(3):443-52. doi: 10.1007/s00432-014-1583-9. Epub 2014 Jan 18. J Cancer Res Clin Oncol. 2014. PMID: 24442098 Free PMC article. Clinical Trial.
-
Targeting Cancer Metabolism - Revisiting the Warburg Effects.Toxicol Res. 2016 Jul;32(3):177-93. doi: 10.5487/TR.2016.32.3.177. Epub 2016 Jul 30. Toxicol Res. 2016. PMID: 27437085 Free PMC article. Review.
-
Haemodialysis studies with dichloroacetate.Eur J Clin Pharmacol. 1991;40(6):613-7. doi: 10.1007/BF00279980. Eur J Clin Pharmacol. 1991. PMID: 1884744
-
Clinical pharmacology and toxicology of dichloroacetate.Environ Health Perspect. 1998 Aug;106 Suppl 4(Suppl 4):989-94. doi: 10.1289/ehp.98106s4989. Environ Health Perspect. 1998. PMID: 9703483 Free PMC article.
-
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.Pharmacol Ther. 2017 Feb;170:166-180. doi: 10.1016/j.pharmthera.2016.10.018. Epub 2016 Oct 19. Pharmacol Ther. 2017. PMID: 27771434 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources